Shanghai Lanxin Medical Technology Group Co., Ltd. (Lanxin Medical) is a professional investment, operation and management group focused on the medical and health field, with a registered capital of 200 million yuan, fixed assets exceeding 1 billion yuan, and more than 1000 employees. Currently, 6 dental hospitals and 1 heart disease hospital have been invested and operated.

Lanxin Medical also has a number of expert advisory teams composed of academicians from the Chinese Academy of Sciences, the Chinese Academy of Engineering and the American Academy of Medicine, providing strong intellectual support for the development of the Group. Lanxin Medical focuses on the development areas of East and Southwest China, investing in the construction and operation of medical service institutions.

 

Lanxin Medical adheres to the concept of people-oriented and patient first, aiming to improve domestic medical standards, cultivate outstanding medical staff, and provide excellent medical services for patients. Lanxin Medical responds to the call of the country to encourage a mixed ownership system with flexible mechanisms. It hopes to integrate and innovate resources, effectively combine advanced medical service concepts, professional management models, brand resources, expert resources, and social capital, build medical service institutions that meet international standards and have a considerable scale, provide the best medical services to the people, gain recognition and support from patients, employees, partners, and the government, and develop into a leading medical group in China.

 

Lanxin Medical's vision is to become a valuable, respected, and internationally influential enterprise in the field of healthcare.